Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Topics and Controversies in Newborn Stem Cell Medicine

In this presentation, originally delivered at Omnia Education’s Women’s Health Annual Visit ®, Dr. Joel Weinthal, a pediatric hematologist and Medi...

Available credits: 0.75

Time to complete: 45 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    In this presentation, originally delivered at Omnia Education’s Women’s Health Annual Visit ®, Dr. Joel Weinthal, a pediatric hematologist and Medical Director of the Stem Cell Lab at Apheresis Medical City Dallas Hospital in Dallas, TX, discusses the science and history of cord blood transplantation and its clinical indications. The potential of regenerative medicine using cord blood stem cells is evaluated and Dr. Weinthal discusses how to incorporate this information into patient counseling practices. For additional tips for counseling patients and families on cord blood donations to public and private banks see Related Content. For additional, certified foundational education see: Related Content.

  • Target Audience

    The target audience for this activity includes practicing Obstetricians and Ob/Gyns, MFM Specialists, CNMs, NPs, and Nurses.

  • Learning Objectives

    After listening to or viewing this educational activity, learners will be better able to:

    • Appreciate the emerging science associated with cord blood transplantation
    • Understand the clinical indications for cord blood transplant
    • Counsel patients and families on cord blood donation to both public and private banks, taking into consideration risk profiles
    • Evaluate the potential of regenerative medicine applications using cord blood stem cells
  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Joel Weinthal, MD
    Pediatric Hematologist/Oncologist
    Medical Director of Stem Cell Lab, Apheresis
    Medical City Dallas Hospital
    Dallas, TX

    Faculty Disclosure:

    • Dr. Weinthal is a consultant for Cord Blood Registry, Shire, and Genzyme.

    The following reviewers/planners/authors have reported real or apparent conflicts of interest that have been resolved:

    • Andy Beloff has nothing to disclose.
    • Sean Saunders, CHCP has nothing to disclose.
    • Elizabeth Stephens has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Emma DelVecchio has nothing to disclose.
  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the providership of The Omnia-Prova Education Collaborative.  The Omnia-Prova Education Collaborative is accredited by the ACCME to provide continuing medical education for physicians. 

    Credit Designation
    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be available for immediate download at

  • Provider(s)/Educational Partner(s)

    This activity is presented by Omnia Education. Omnia Education designs educational programs based on evidence-based medicine, needs and gaps analyses, learner feedback, and more. Its mission is to serve as an innovative and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

  • Commercial Support

    This activity was made possible through an educational grant from Cord Blood Registry.

  • Terms of Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither Prova Education nor TOPEC recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Prova Education or TOPEC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Instructions

    There are no fees for participating in and receiving CME credit for this activity. During the period December 3, 2015, through December 3, 2016, participants must 1) read the learning objectives and faculty disclosures; 2) listen to the full content of the activity and reflect upon its teachings; 3) successfully complete the post-test with a passing score and the evaluation at the end of the activity.

    Participants who successfully complete the activity, post-test and evaluation will have a statement of credit made available immediately.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ReachMD you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.